Specifically, alterations in plasma MCP-1 concentrations in metabolic disease states, the presence of circulating chemokine reservoirs, recent evidence of novel mechanisms of action, and certain unexplained responses associated with metabolic disturbances suggest that MCP-1 might have a systemic role in metabolic regulation [48–50]. The gene discussed is CCL2; the disease is metabolic disease.